4/A
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-21-028356
Options or other derivatives
- Chief Financial Officer acquired 54,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Musil Clinton Chief Financial Officer | 2021-02-08 | Grant or award · Stock Option (Right to Buy) | +54,000 | 54,000 | D: show line 1 in the form |
Loading xslF345X03/doc4a.xml…